Saba Capital Income & Opportunities Fund II (NYSE:SABA – Get Free Report) major shareholder Saba Capital Management, L.P. sold 4,453 shares of the business’s stock in a transaction that occurred on Monday, September 23rd. The shares were sold at an average price of $8.46, for a total value of $37,672.38. Following the completion of the transaction, the insider now directly owns 3,450,271 shares in the company, valued at approximately $29,189,292.66. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Major shareholders that own at least 10% of a company’s shares are required to disclose their sales and purchases with the SEC.
Saba Capital Income & Opportunities Fund II Stock Down 0.5 %
SABA stock traded down $0.04 on Tuesday, reaching $8.39. 98,407 shares of the company’s stock were exchanged, compared to its average volume of 117,340. Saba Capital Income & Opportunities Fund II has a twelve month low of $7.28 and a twelve month high of $8.65.
Saba Capital Income & Opportunities Fund II Announces Dividend
The business also recently disclosed a monthly dividend, which will be paid on Monday, September 30th. Investors of record on Tuesday, September 10th will be paid a dividend of $0.058 per share. This represents a $0.70 dividend on an annualized basis and a dividend yield of 8.30%. The ex-dividend date is Tuesday, September 10th.
Hedge Funds Weigh In On Saba Capital Income & Opportunities Fund II
Saba Capital Income & Opportunities Fund II Company Profile
Saba Capital Income & Opportunities Fund II is a closed-ended fixed income mutual fund launched and managed by Saba Capital Management, L.P. The fund invests in fixed income markets across the globe. It primarily invests in government bonds. The fund is actively managed. It benchmarks the performance of its portfolio against the J.P.
Featured Stories
- Five stocks we like better than Saba Capital Income & Opportunities Fund II
- What is the FTSE 100 index?
- Biohaven Stock Soars on Drug Trial Results: Time to Jump In?
- What is the Euro STOXX 50 Index?
- Is AMD a Legitimate Threat to NVIDIA? What Investors Should Watch
- How to Invest in Blue Chip Stocks
- Novo Nordisk’s Setback Won’t Last: A Game-Changing Drug Emerges
Receive News & Ratings for Saba Capital Income & Opportunities Fund II Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Saba Capital Income & Opportunities Fund II and related companies with MarketBeat.com's FREE daily email newsletter.